Synmosa Biopharma Corporation replaced Fan, De-Quan as Independent Director of the company with Wang Chien-Jen, effective date is May 25, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
41.15 TWD | -0.48% | -0.60% | +6.47% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+6.47% | 484M | |
+55.32% | 815B | |
+44.05% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.57% | 242B | |
+13.31% | 218B | |
+8.48% | 168B | |
-2.81% | 159B |
- Stock Market
- Equities
- 4114 Stock
- News Synmosa Biopharma Corporation
- Synmosa Biopharma Corporation Announces Wang Chien-Jen as Independent Director